Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

32.89

+0.87 (2.72%)

At close: Aug 7, 2026, 4:00 PM EDT

32.99

+0.10 (0.30%)

After-hours: Aug 7, 2026, 7:34 PM EDT

Vera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-368.95	-299.62	-152.15	-95.99	-89.06	-32.61
Depreciation & Amortization	0.52	0.47	0.11	0.02	-0.85	0.18
Stock-Based Compensation	43.39	37.93	20.8	11.49	8.89	3.01
Other Adjustments	13.14	-2.88	-6.1	-1.88	6.67	2.2
Changes in Other Operating Activities	18.7	22.99	2.66	-5.82	6.75	3.51
Operating Cash Flow	-293.2	-241.1	-134.68	-92.18	-67.6	-23.71
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-0.47	-0.63	-0.97	-0.06	-0.06	-
Purchases of Intangible Assets	-0.15	-	-	-	-	-
Purchases of Investments	-431.02	-310.45	-703.02	-224.93	-148.49	-
Proceeds from Sale of Investments	487.83	506.16	278.96	185.56	78	-
Other Investing Activities	-15.05	-0.8	-	-	-	-4.2
Investing Cash Flow	41.15	194.29	-425.03	-39.43	-70.55	-4.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	-	23.34	-	24.74	19.82	4.92
Net Long-Term Debt Issued (Repaid)	-	23.34	-	24.74	19.82	4.92
Issuance of Common Stock	9.39	306.98	645.91	116.06	88.21	51.73
Repurchase of Common Stock	-	-	-0.01	-	-	-
Net Common Stock Issued (Repurchased)	9.39	306.98	645.9	116.06	88.21	51.73
Other Financing Activities	-	-21.42	-39.23	-7.26	-6.1	-2.77
Financing Cash Flow	311.31	308.9	606.67	133.54	101.93	53.88

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	59.26	262.08	46.97	1.93	-36.22	25.97

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-293.66	-241.73	-135.65	-92.24	-67.66	-23.71
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-4.41	-3.76	-2.45	-2.16	-2.55	-1.76
Levered Free Cash Flow	-350.19	-253.45	-150.36	-77.11	-63.4	-24
Unlevered Free Cash Flow	-364.65	-292.64	-165.38	-107.88	-85.07	-30.72

SEC Filings: 10-K · 10-Q